Thermo
Amount not stated
Company reimburses Thermo for expenses incurred by Messrs. Monroe, Lynch and Taylor and other Thermo employees serving the Company, with no mark-up.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Company reimburses Thermo for expenses incurred by Messrs. Monroe, Lynch and Taylor and other Thermo employees serving the Company, with no mark-up.
General and administrative expenses incurred by Thermo on the Company's behalf.
Services provided to the Company by an officer of Thermo, accounted for as a non-cash contribution to capital.
Payments for services provided by other consultants and Thermo employees.
Headquarters office lease agreement with a ten-year term, expiring January 2029, with annual payments increasing 2.5% per year.
Thermo holds Series A Preferred Stock with an aggregate liquidation preference.
Dividend payments made to Thermo on the Series A Preferred Stock, approved by the Board.
Lock-up and right of first offer agreement restricting transfers of Company common stock by Thermo for five years from launch of services.
Thermo guaranty of certain amounts under the 2023 Funding Agreement and Services Agreements, with the Company issuing Thermo a warrant to purchase 666,668 shares as consideration.
Amended Thermo Guaranty lowering the Guaranteed Obligations cap.
Intellectual property License Agreement, terminated January 2026; Company issued 4.0 million shares of common stock to Virewirx.
Company issued 1.1 million additional shares to Dr. Jacobs as consideration under the License Agreement.
Support Services Agreement under which Virewirx provided services; Company issued 0.7 million shares in August 2023 and 0.5 million shares in June 2024 as payment and release of holdback shares.
Virewirx sold 0.3 million and 0.2 million Company shares in private placements to an affiliate of Thermo.
Loading...
